Omicron vaccine is all well and good, but the real money is on an all-in-one jab
Researchers look for alternative strategy as variant-specific vaccines seem doomed to play perpetual catch-up
20 January 2022 - 20:56
Pfizer and Moderna are starting to churn out doses of Omicron-specific vaccines, and they say they could have data on whether the shots are effective as soon as March. But is this the best way to build and maintain protection against Covid-19?..